TherapeuticsMD | TXMD - Current Assets


TherapeuticsMD reported $11.82M in Current Assets for its fiscal quarter ending in June of 2024.





Current Assets Change Date
AbbVie USD 29.06B 523M Dec/2025
Alterity Therapeutics Limited AUD 27.05M 6.16M Jun/2023
Cipla INR 249.18B 16.3B Sep/2025
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 88.92M 8.72M Sep/2025
CSL USD 11.85B 1000K Dec/2025
Grifols EUR 6.28B 92.48M Sep/2025
Novo Nordisk DKK 25.71B 148.69B Jun/2025
Pfizer USD 46.92B 3.22B Sep/2025
TherapeuticsMD USD 11.82M 303K Jun/2024